Melanoderma as a side effect of cortisone depot therapy
Rainova, R.; Kaloianov, K.
Vutreshni Bolesti 13(2): 120-122
1974
ISSN/ISBN: 0506-2772 PMID: 4370659 Document Number: 75352
Document emailed within 1 workday
Related Documents
Sippell, W.G.; Partsch, C.J.; Hümmelink, R.; Lorenzen, F. 1994: Long-term therapy of true precocious puberty in girls using Decapetyl-Depot, a superactive gonadoliberin agonist in depot microcapsulated form Ceskoslovenska Pediatrie 49(1): 13-18Zeron-Medina, F.; Romero Garcia, F. 1970: Side effects of a depot progestational agent La Prensa Medica Mexicana 35(5): 277-279
Day, S.; Graham, S.M.; Masese, L.N.; Richardson, B.A.; Kiarie, J.N.; Jaoko, W.; Mandaliya, K.; Chohan, V.; Overbaugh, J.; McClelland, R.S. 2014: A prospective cohort study of the effect of depot medroxyprogesterone acetate on detection of plasma and cervical HIV-1 in women initiating and continuing antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 66(4): 452-456
Peterson, S.H. 1977: Arthralgia as a side effect of methyldopa therapy Journal of the American Osteopathic Association 76(5): 376
Fazekas, T.; Remák, G. 1985: Hyperthyroidism as a side effect of amiodarone therapy Orvosi Hetilap 126(38): 2339-2341
Borup Johansen, N.; Ayadipanah, M.; Sonnenschein, E.S.; Christensen, H.R.; Jürgens, G. 2013: Dizziness as a side effect of pharmacological therapy Ugeskrift for Laeger 175(45): 2720-2725
Liebetrau, G. 1984: Alveolitis--a rare side effect of gold therapy Zeitschrift für Erkrankungen der Atmungsorgane 163(2): 200-204
Abuzarad, H.; Gadallah, M.F.; Rabb, H.; Vermess, M.; Ramirez, G. 1998: Emphysematous cystitis: possible side-effect of cyclophosphamide therapy Clinical Nephrology 50(6): 394-396
Chaudhuri, M.D.; Bhan, G.L. 1984: Deep vein thrombosis: a side effect of steroid therapy British Journal of Clinical Practice 38(3): 118-119
Karayianni, M.; von Heijne, A.; Laska, A-Charlotte. 2017: Encefalopathy as a side effect of metronidazole therapy – a case report Lakartidningen 114
Reichert, R.A.; Weissman, I.L.; Butcher, E.C. 1986: Dual immunofluorescence studies of cortisone-induced thymic involution: evidence for a major cortical component to cortisone-resistant thymocytes Journal of Immunology 136(10): 3529-3534
Nyfors, A. 1980: Methotrexate therapy of psoriasis. Effect and side effects with particular reference to hepatic changes. A survey Danish Medical Bulletin 27(2): 74-96
Paik, N.J.; Han, T.R.; Im, M.S. 2001: Effect of facilitation on side-to-side H reflex amplitude ratio Electromyography and Clinical Neurophysiology 41(1): 3-7
von Schrader, H.W.; Buscher, G.; Dierdorf, D.; Freytag, A.; Mügge, H.; Wolf, D. 1985: Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets Arzneimittel-Forschung 35(9): 1468-1472
Vogt, J.H. 1972: Therapy with cortisone, cortisonoids and ACTH Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 92(11): 807-811
Sutnick, A.I.; Cronlund, M.M.; Ambacher, S.B. 1970: Cortisone therapy and pulmonary surfactant Research Communications in Chemical Pathology and Pharmacology 1(1): 57-66
Rabenalt, P. 1978: Monocytic neck lymphadenitis with morbileiform exanthema as side effect of penicillamine therapy of infantile Wilson's diseases Kinderarztliche Praxis 46(8): 436-439
Francke, C.; Rookus, P.; Weyne, W. 1954: A case of phosphorus poisoning with cortisone therapy Nederlands Tijdschrift Voor Geneeskunde 98(16): 1071-1074
Greene, J. 2002: Side by side. Communication is key to a successful side by side CEO-board chair partnership Trustee: the Journal for Hospital Governing Boards 55(5): 6
Tsyrkunov, L.P. 1985: Toxic melanoderma of occupational etiology Vestnik Dermatologii i Venerologii 9: 53-56